Literature DB >> 29177794

Imaging of the thymus in myotonic dystrophy type 1.

Andrea Mignarri1, Francesco Gentili2, Francesco Masia3, Angelo Genua3, Silvia Cenciarelli4, Paola Brunori5, Maria Antonietta Mazzei2, Alessandro Malandrini6, Antonio Federico6, Francesco Giuseppe Mazzei7, Maria Teresa Dotti6.   

Abstract

The occurrence of thymoma in myotonic dystrophy type 1 (DM1) has been occasionally reported, and an increased risk of tumors has been observed. We performed imaging of the thymus in 22 patients carrying DMPK expansion. Clinical examination and routine instrumental exams were performed at the same time. We observed no thymic abnormalities in 13 subjects, thymic hyperplasia in eight patients, and an invasive thymoma in one case. Subjects with thymic abnormalities did not show peculiarities as regards clinical and electrophysiological features. We observed thymoma in one patient with an expansion in the higher range. Abnormalities of the thymus including hyperplasia and thymoma can be present in DM1, but do not seem to play a major role in DM1 pathogenesis. Further studies are needed to understand if some RNA splicing factors involved in DM1 and influenced by CTG expansion size could have a role in thymocytes proliferation.

Entities:  

Keywords:  DMPK; Myotonic dystrophy type 1; Thoracic imaging; Thymic hyperplasia; Thymoma; Thymus

Mesh:

Substances:

Year:  2017        PMID: 29177794     DOI: 10.1007/s10072-017-3202-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  28 in total

1.  Cancer risk among patients with myotonic muscular dystrophy.

Authors:  Shahinaz M Gadalla; Marie Lund; Ruth M Pfeiffer; Sanne Gørtz; Christine M Mueller; Richard T Moxley; Sigurdur Y Kristinsson; Magnus Björkholm; Fatma M Shebl; James E Hilbert; Ola Landgren; Jan Wohlfahrt; Mads Melbye; Mark H Greene
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

Review 2.  Clinical and radiologic review of the normal and abnormal thymus: pearls and pitfalls.

Authors:  Farbod Nasseri; Farzin Eftekhari
Journal:  Radiographics       Date:  2010-03       Impact factor: 5.333

3.  [Myotonic dystrophy and thymoma associated with myasthenic behavior on electromyography].

Authors:  A Cánovas; E Rodríguez Illera; A Arizcun; C Riva; J Diego
Journal:  Rev Clin Esp       Date:  1981-03-31       Impact factor: 1.556

4.  Correlates of tumor development in patients with myotonic dystrophy.

Authors:  Maya Das; Richard T Moxley; James E Hilbert; William B Martens; Lisa Letren; Mark H Greene; Shahinaz M Gadalla
Journal:  J Neurol       Date:  2012-05-23       Impact factor: 4.849

5.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

6.  Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; D Meunier; M Gaudreault; P Bégin
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

7.  Myotonic dystrophy type 1 coexisting with myasthenia gravis and thymoma.

Authors:  Timothy Feyma; Gregory T Carter; Michael D Weiss
Journal:  Muscle Nerve       Date:  2008-07       Impact factor: 3.217

8.  Undiagnosed myotonic dystrophy type 1 in a patient with synchronous thymoma and thyroid cancer.

Authors:  M Teresa Gómez Hernández; M Teresa Martín Posadas; M Del Carmen García Sánchez
Journal:  Arch Bronconeumol       Date:  2015-11-23       Impact factor: 4.872

Review 9.  Hypothesis: neoplasms in myotonic dystrophy.

Authors:  Christine M Mueller; James E Hilbert; William Martens; Charles A Thornton; Richard T Moxley; Mark H Greene
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

Review 10.  Thymoma and myotonic dystrophy: successful treatment with chemotherapy and radiation: case report and review of the literature.

Authors:  Ganesh C Kudva; Kochurani Maliekel; Han J Kim; Keith S Naunheim; Cary Stolar; James W Fletcher; Sanjeev Puri
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

View more
  2 in total

1.  CT texture analysis in evaluation of thymic tumors and thymic hyperplasia: correlation with the international thymic malignancy interest group (ITMIG) stage and WHO grade.

Authors:  Naveen Rajamohan; Ankur Goyal; Devasenathipathy Kandasamy; Ashu Seith Bhalla; Rajinder Parshad; Deepali Jain; Raju Sharma
Journal:  Br J Radiol       Date:  2021-10-05       Impact factor: 3.039

2.  Loss of MBNL1 induces RNA misprocessing in the thymus and peripheral blood.

Authors:  Łukasz J Sznajder; Marina M Scotti; Jihae Shin; Katarzyna Taylor; Franjo Ivankovic; Curtis A Nutter; Faaiq N Aslam; S H Subramony; Laura P W Ranum; Maurice S Swanson
Journal:  Nat Commun       Date:  2020-04-24       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.